ArticleDiscover oncology2026

Pan-cancer multi-omics analysis identifies SYNGR4 as a novel clinical prognostic biomarker and therapeutic target in lung adenocarcinoma.

Yanjiao Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.